{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:49:52Z","timestamp":1787060992287,"version":"build-2736575974"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Septic shock is associated with high morbidity and mortality. Studies have reported that Chinese herbal injections (CHIs) in combination with Western medicine (WM) were more favorable. However, the debate on optimal CHIs is ongoing. The objective of this study is to explore the comparative effectiveness of CHIs for septic shock.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We retrieved data from the English and Chinese databases with retrieval time from database inception to 30 September 2021. Network meta-analysis was performed, with evaluation of methodological quality among the included studies and assessment of strength of evidence among the outcomes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 77 RCTs with 5,647 patients were included. All the studies were rated as some concerns. In terms of 28-days-mortality, Yiqifumai injection (YQFM)+WM, Shuxuetong injection (SXT)+WM, Xuebijing injection (XBJ)+WM, and Shenfu injection (SF)+WM were better than WM; YQFM + WM and SXT + WM were superior for Shenmai injection (SM)+WM; YQFM + WM was superior for SF + WM; YQFM + WM ranked first. Regarding ICU length of stay, SF + WM and XBJ + WM were better than WM; XBJ + WM was superior for SF + WM; XBJ + WM ranked first. Concerning hospital length of stay, Shenqifuzheng injection (SQFZ)+WM, Shengmai injection (SGM)+WM, and XBJ + WM had greater potential than WM and SF + WM; SQFZ + WM ranked first. As for SOFA score at 7-days, XBJ + WM and SF + WM were superior for WM; XBJ + WM was superior for SF + WM; XBJ + WM ranked first. Regarding procalcitonin level at 7-days, SF + WM, SM + WM, and Xiyanping injection (XYP)+WM were better than WM; XYP + WM was superior for SF + WM, SGM + WM, SM + WM, Danshen injection (DS)+WM, and XBJ + WM; XYP + WM ranked first. Concerning serum lactate level at 7-days, SF + WM and SM + WM were more effective than XBJ + WM and WM; SM + WM ranked first. The comparisons were rated as moderate (15.05%), low (40.86%), and very low quality (44.09%); the strength of evidence of ranking probability for hospital length of stay was low whereas the remaining outcomes were rated as very low.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    CHIs combined with WM might have higher efficacies for septic shock than WM alone. YQFM, XBJ, SQFZ, XYP, SM, SGM, and SF may be the potential optimal CHIs for septic shock. More and better evidence is needed to validate the conclusions.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Systematic Review Registration:<\/jats:bold>\n                    <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?<\/jats:ext-link>\n                    , identifier CRD42021282958.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.850221","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:44:06Z","timestamp":1649310246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Efficacy of Chinese Herbal Injections for Septic Shock: A Bayesian Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Peiying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone Plus Fludrocortisone for Adults with Septic Shock","volume":"378","author":"Annane","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e12680","DOI":"10.1111\/micc.12680","article-title":"Post\u2010treatment with Yiqifumai Injection and its Main Ingredients Attenuates Lipopolysaccharide\u2010induced Microvascular Disturbance in Mesentery and Ileum","volume":"28","author":"Ayididaer","year":"2021","journal-title":"Microcirculation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in Sepsis and Septic Shock in Europe, North America and Australia between 2009 and 2019-results from a Systematic Review and Meta-Analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit. Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General Methods for Monitoring Convergence of Iterative Simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J. Comput. Graph. Stat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous Comparison of Multiple Treatments: Combining Direct and Indirect Evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7501\/j.issn.1674-6376.2019.03.015","article-title":"Clinical Safety Monitoring Study of Yiqi Fumai Lyophilized Injection","volume":"42","author":"Cao","year":"2019","journal-title":"Drug Eval. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3969\/j.issn.2095-7629.2018.08.119","article-title":"Clinical Application Characteristics and Safety Evaluation of Shenqi Fuzheng Injection","volume":"16","author":"Chen","year":"2018","journal-title":"Contemp. Med. Forum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence Synthesis for Decision Making 2: a Generalized Linear Modeling Framework for Pairwise and Network Meta-Analysis of Randomized Controlled Trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med. Decis. Making"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.4268\/cjcmm20150735","article-title":"Predictive Analysis on Shenmai Injection-Induced Adverse Reactions with Logistic Model and ROC Curve","volume":"40","author":"Ding","year":"2015","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3969\/j.issn.1004-745X.2019.11.004","article-title":"Effect of Shengmai Injection on Septic Shock,a Systematic Review and Meta-Analyse","volume":"28","author":"Ha","year":"2019","journal-title":"J. Emerg. Traditional Chin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.15887\/j.cnki.13-1389\/r.2014.01.012","article-title":"Effect of Shenmai Injection on Immunological Function in Sepsis Rats","volume":"7","author":"He","year":"2014","journal-title":"Chin. J. Clin. Rational Drug Use"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta\u2010analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3969\/j.issn.1006-4931.2012.21.021","article-title":"Safety Evaluation of Shenqifuzheng Injection","volume":"21","author":"Hu","year":"2012","journal-title":"China Pharmaceuticals"},{"key":"B16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"010404","DOI":"10.7189\/jogh.02.010404","article-title":"Assessing Available Information on the burden of Sepsis: Global Estimates of Incidence, Prevalence and Mortality","volume":"2","author":"Jawad","year":"2012","journal-title":"J. Glob. Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus Disease 2019 as Cause of Viral Sepsis: a Systematic Review and Meta-Analysis","volume":"49","author":"Karakike","year":"2021","journal-title":"Crit. Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"Jama"},{"key":"B20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1473-3099(12)70239-6","article-title":"Outcomes of the Surviving Sepsis Campaign in Intensive Care Units in the USA and Europe: a Prospective Cohort Study","volume":"12","author":"Levy","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The Surviving Sepsis Campaign Bundle: 2018 Update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"113301","DOI":"10.1016\/j.jep.2020.113301","article-title":"The Current Evidence for the Treatment of Sepsis with Xuebijing Injection: Bioactive Constituents, Findings of Clinical Studies and Potential Mechanisms","volume":"265","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12553","DOI":"10.1111\/micc.12553","article-title":"Yiqifumai Injection and its Main Ingredients Attenuate Lipopolysaccharide\u2010induced Cerebrovascular Hyperpermeability through a Multi\u2010pathway Mode","volume":"26","author":"Li","year":"2019","journal-title":"Microcirculation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/pds.4805","article-title":"Safety Profile of Traditional Chinese Herbal Injection: An Analysis of a Spontaneous Reporting System in China","volume":"28","author":"Li","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.7501\/j.issn.1674-6376.2019.10.032","article-title":"Analysis of Yiqi Fumai Lyophilized Injection Application and Adverse Reaction","volume":"42","author":"Li","year":"2019","journal-title":"Drug Eval. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-9-79","article-title":"Network Meta-Analysis-Highly Attractive but More Methodological Research Is Needed","volume":"9","author":"Li","year":"2011","journal-title":"BMC Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3321\/j.issn:1003-5370.2009.11.001","article-title":"Systematic Review on the Application and Adverse Reactions of Shengmai Injection","volume":"29","author":"Li","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jtcm.2017.05.001","article-title":"Effectiveness and Safety of Shenmai Injection in Treatment of Shock:a Meta-Analysis","volume":"38","author":"Li","year":"2018","journal-title":"J. Tradit. Chin. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.19539\/j.cnki.2095-2694.2016.05.016","article-title":"Effect of Shenqi Fuzheng Injection on Heat Shock Protein-70 in Lung Tissue of Rats with Endotoxin Induced Acute Lung Injury","volume":"18","author":"Liang","year":"2016","journal-title":"J. HeBei United Univ. (Health Sciences)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3969\/j.issn.1004-745X.2021.02.052","article-title":"Research Progress in the Treatment of Septic Shock with Integrated Traditional Chinese and Western Medicine","volume":"30","author":"Liang","year":"2021","journal-title":"J. Emerg. Traditional Chin. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3969\/j.issn.1005-4561.2013.09.007","article-title":"Effects of Shenmai Injection on Renal Apoptosis and Expressions of the Bcl-2\/Bax Protein in Septic Rats","volume":"23","author":"Lin","year":"","journal-title":"Zhejiang J. Integrated Traditional Chin. West. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.13193\/j.archtcm.2013.07.207.linms.085","article-title":"Effects of Shenmai Iniection on Myocardial Apoptosis in Septic Rats","volume":"31","author":"Lin","year":"","journal-title":"Zhonghua Zhongyiyao Xuekan"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.15887\/j.cnki.13-1389\/r.2018.27.052","article-title":"Analysis of Clinically Unreasonable Application in Compatibility of Traditional Chinese Medicine Injections","volume":"11","author":"Liu","year":"2018","journal-title":"Chin. J. Clin. Rational Drug Use"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11655-021-3292-Y","article-title":"Mechanism of Shengmai Injection on Anti-sepsis and Protective Activities of Intestinal Mucosal Barrier in Mice","author":"Lu","year":"2021","journal-title":"Chin. J. Integr. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: a Retrospective Before-After Study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/0962280211432219","article-title":"A Practical Introduction to Multivariate Meta-Analysis","volume":"22","author":"Mavridis","year":"2013","journal-title":"Stat. Methods Med. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to Use an Article Reporting a Multiple Treatment Comparison Meta-Analysis","volume":"308","author":"Mills","year":"2012","journal-title":"Jama"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc12598","article-title":"The Epidemiology of Septic Shock in French Intensive Care Units: the Prospective Multicenter Cohort EPISS Study","volume":"17","author":"Quenot","year":"2013","journal-title":"Crit. Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the Quality of Evidence from a Network Meta-Analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of Networks of Randomized Trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat. Methods Med. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and Mixed\u2010treatment Comparison, Network, or Multiple\u2010treatments Meta\u2010analysis: many Names, many Benefits, many Concerns for the Next Generation Evidence Synthesis Tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/bja\/aex234","article-title":"Epidemiology of Sepsis and Septic Shock in Critical Care Units: Comparison between Sepsis-2 and Sepsis-3 Populations Using a National Critical Care Database","volume":"119","author":"Shankar-Hari","year":"2017","journal-title":"Bja: Br. J. Anaesth."},{"key":"B44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"Jama"},{"key":"B45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/bmj.316.7129.469","article-title":"Bias in Meta-Analysis Detected by a Simple, Graphical Test. Asymmetry Detected in Funnel Plot Was Probably Due to True Heterogeneity","volume":"316","author":"Stuck","year":"1998","journal-title":"Bmj: Br. Med. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.16458\/j.cnki.1007-0893.2019.04.018","article-title":"Impact of Clinical Pharmacist's Interventions in Rational Use of Traditional Chinese Medicine Injection","volume":"29","author":"Tan","year":"2019","journal-title":"Shenzhen Zhongxiyi Jiehe Zazhi"},{"key":"B49","doi-asserted-by":"publisher","first-page":"SIV9","DOI":"10.1016\/s0140-6736(99)90352-5","article-title":"The Past 1000 Years of Chinese Medicine","volume":"354","author":"Unschuld","year":"1999","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.biopha.2018.10.190","article-title":"Reevaluation of the post-marketing Safety of Xuebijing Injection Based on Real-World and Evidence-Based Evaluations","volume":"109","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3321\/j.issn:1003-5370.2007.01.013","article-title":"Effect of Shenqi Fuzheng Injection on Fractalkine Expression in Lung Tissue of Rats with Lipopolysaccharide-Induced Acute Lung Injury","volume":"27","author":"Wang","year":"2007","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.13457\/j.cnki.jncm.2015.03.002","article-title":"Analysis of Mechanism of Shenfu Injection in Treating Septic Shock","volume":"47","author":"Wang","year":"2015","journal-title":"J. New Chin. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.19540\/j.cnki.cjcmm.20180815.004","article-title":"Retrospective Analysis and Discussion on 74 Cases of Adverse Reactions of Traditional Chinese Medicine Injection","volume":"43","author":"Wang","year":"2018","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"B54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.13201\/j.issn.1009-5918.2020.07.001","article-title":"Consensus of Chinese Experts on Early Prevention and Blocking of Sepsis","volume":"21","author":"Wang","year":"2020","journal-title":"J. Clin. Emerg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7501\/j.issn.1674-6376.2018.03.004","article-title":"Effect of Yiqi Fumai Lyophilized Injection on Lipopolysaccharide-Induced Acute Lung Injury in Mice","volume":"41","author":"Xia","year":"2018","journal-title":"Drug Eval. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4268\/cjcmm20131803","article-title":"Technical Specifications for Rational Clinical Use of Parenterally Administered Chinese Medicine (Draft Version for Comments)","volume":"38","author":"Xie","year":"2013","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-8-10","article-title":"Attenuating Effect of Pretreatment with Yiqifumai on Lipopolysaccharide-Induced Intestine Injury and Survival Rate in Rat","volume":"8","author":"Yuan","year":"2011","journal-title":"J. Inflamm."},{"key":"B58","volume-title":"Manual for the Rational Use of Traditional Chinese Medicine Injections Clinically","author":"Zhang","year":"2016"},{"key":"B59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1756-5391.2010.01089.x","article-title":"Adverse Drug Reactions of Shenmai Injection: a Systematic Review","volume":"3","author":"Zhang","year":"2010","journal-title":"J. Evidence-based Integr. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.13488\/j.smhx.20180102","article-title":"Progress in the Study of In Vivo Distribution and Anti-inflammatory Mechanism of Andrographolide and its Derivatives","volume":"38","author":"Zhang","year":"2018","journal-title":"Chem. Life"},{"key":"B61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3969\/j.issn.1673-7210.2006.23.073","article-title":"Analysis of 1089 Cases of Clinical Adverse Reactions of Xiyanping Injection","volume":"3","author":"Zheng","year":"2006","journal-title":"China Med. Herald"},{"key":"B62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21037\/atm.2018.09.26","article-title":"A Real-World Study on Adverse Drug Reactions to Xuebijing Injection: Hospital Intensive Monitoring Based on 93 Hospitals (31,913 Cases)","volume":"7","author":"Zheng","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.13193\/j.issn.1673-7717.2016.09.032","article-title":"Xuebijing Injection Reducing Mortality of Septic Shock Patients : A Systematic Review and Meta-Analysis","volume":"34","author":"Zhou","year":"2016","journal-title":"Chin. Arch. Traditional Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.850221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:44:27Z","timestamp":1649310267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.850221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":63,"alternative-id":["10.3389\/fphar.2022.850221"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.850221","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"850221"}}